SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-003565
Filing Date
2023-02-15
Accepted
2023-02-14 18:02:09
Documents
14
Period of Report
2023-02-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K ardx-20230209.htm   iXBRL 8-K 33081
6 ardx-20230209_g1.jpg GRAPHIC 2570
  Complete submission text file 0001628280-23-003565.txt   213079

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ardx-20230209.xsd EX-101.SCH 2153
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ardx-20230209_def.xml EX-101.DEF 15312
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ardx-20230209_lab.xml EX-101.LAB 29720
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ardx-20230209_pre.xml EX-101.PRE 15969
8 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20230209_htm.xml XML 11781
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36485 | Film No.: 23632399
SIC: 2834 Pharmaceutical Preparations